Market capitalization is the total value the stock market puts on a company: its share price multiplied by the number of shares outstanding. Each point here is the share count reported in a filing multiplied by the closing price on that filing date, adjusted for later stock splits, so the history moves when a new filing arrives rather than with each day's trading. A larger market cap means investors collectively value the company more highly; by itself it says nothing about profit or debt. Annual points keep the latest observation in each calendar year.
Cullinan Therapeutics, Inc. market cap for the quarter ending 2026-07-31 was $1.06B, a 131.79% increase year-over-year.
Cullinan Therapeutics, Inc. market cap for the quarter ending 2026-06-30 was $1.17B, a 163.76% increase year-over-year.
Cullinan Therapeutics, Inc. market cap for the quarter ending 2026-04-30 was $801.41M, a 64.01% increase year-over-year.
Cullinan Therapeutics, Inc. market cap for the quarter ending 2026-03-31 was $872.61M, a 96.38% increase year-over-year.
Cullinan Therapeutics, Inc. market cap for fiscal 2026 was $1.06B.
Cullinan Therapeutics, Inc. market cap for fiscal 2025 was $622.32M, a 12.68% decline from fiscal 2024.
Cullinan Therapeutics, Inc. market cap for fiscal 2024 was $712.66M, a 63.02% increase from fiscal 2023.
Cullinan Therapeutics, Inc. market cap for fiscal 2023 was $437.15M, a 9.52% decline from fiscal 2022.